GLAUKOS CORP

Glaukos (GKOS) shares up 1.24% to $178.88, outperforming peers. With a 10.6B market cap and 52‑week high at $191.62, investors see sustained upside and strong long‑term trend.

Glaukos (GKOS) shares hit $176.69, a slight dip after a 15% monthly rise and trading above its 200‑day SMA, outperforming peers and showing strong bullish momentum.

Glaukos shares rise 1.97% as investors rally behind its cutting‑edge glaucoma therapies, positioning the stock near a breakout above the 200‑day average.

Glaukos (GKOS) up 3.88% – $176.85/share, $9.8B cap. Eye‑care tech firm boosts glaucoma treatments, trading volume $106.5M. Get real‑time insights.